Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature

被引:17
|
作者
Zheng, Yawen [1 ]
Yin, Qihui [1 ]
Yang, Xingsheng [1 ]
Dong, Ruiying [1 ]
机构
[1] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Cheeloo Coll Med, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
关键词
Low-grade endometrial stromal sarcoma (LGESS); fertility-sparing management; SEER; hormonal therapy; recurrence; CONSERVATIVE MANAGEMENT; SUCCESSFUL PREGNANCY; SURGERY; DIAGNOSIS; TUMORS;
D O I
10.21037/atm-20-2180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Low-grade endometrial stromal sarcoma (LGESS) is the second most common malignant mesenchymal tumor of the uterus which usually affects young women. However, the researches on the safety and feasibility of the fertility-sparing management of it are limited. Methods: A retrospective analysis was performed including 5 women diagnosed with LGESS treated with fertility-sparing management at Qilu Hospital of Shandong University from 2010 to 2019. Besides that, 1,070 patients diagnosed with LGESS in SEER database from 1973 to 2016 were examined. By using the Kaplan- Meier method, survival curves were estimated, and comparisons of statistical significance were performed with the stratified log-rank test within each group. Results: Five patients with LGESS were enrolled in this study. All patients were submitted to fertilitysparing surgeries, after surgery, they all continued hormonal therapy for one year. Four out of the 5 patients recurred, to be more exact, 3 of them recurred in uterus and the other one in the uterus and iliac vascular region. They all suffered further surgery and all 5 patients were alive at the time of last contact. Besides, among these patients, two conceived naturally and delivered a healthy baby by cesarean section. Among 1,070 patients in SEER database, only 28 (2.6%) patients underwent local tumor excision, including excisional biopsy (39%), myomectomy (25%), laser ablation or excision (4%) and polypectomy (4%). There was no statistical significance was observed among THBSO, radical hysterectomy, subtotal hysterectomy and local tumor excision (P=0.29). Conclusions: Our analysis indicated that for those young LGESS patients who wish to preserve their fertility, the feasibility and safety of fertility-sparing management should be considered after gynecological oncologist and gynecological pathologist making professional decisions.
引用
收藏
页数:10
相关论文
共 42 条
  • [31] MICROSURGICAL MANAGEMENT OF LOW-GRADE SPINAL CORD ASTROCYTOMA IN ADULTS: A PERSONAL CASE SERIES REPORT AND BRIEF LITERATURE REVIEW
    Pojskic, Mirza
    Rotim, Kresimir
    Splavski, Bruno
    Arnautovic, Kenan I.
    ACTA CLINICA CROATICA, 2020, 59 (03) : 505 - 512
  • [32] LOW-GRADE STROMAL SARCOMA - A BENIGN APPEARING MALIGNANT UTERINE-TUMOR - A REVIEW OF CURRENT LITERATURE - DIFFERENTIAL DIAGNOSTIC PROBLEMS ILLUSTRATED BY 4 CASES
    BOHR, L
    THOMSEN, CF
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1991, 39 (01): : 63 - 69
  • [33] Liver Transplantation for Langerhans Cell Histiocytosis: A US Population-Based Analysis and Systematic Review of the Literature
    Ziogas, Ioannis A.
    Kakos, Christos D.
    Wu, W. Kelly
    Montenovo, Martin, I
    Matsuoka, Lea K.
    Zarnegar-Lumley, Sara
    Alexopoulos, Sophoclis P.
    LIVER TRANSPLANTATION, 2021, 27 (08) : 1181 - 1190
  • [34] Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis
    Shemesh S.S.
    Acevedo-Nieves J.D.
    Pretell-Mazzini J.
    MUSCULOSKELETAL SURGERY, 2018, 102 (2) : 95 - 109
  • [35] Is reduction better than arthrodesis in situ in surgical management of low-grade spondylolisthesis? A system review and meta analysis
    Bai, Xuedong
    Chen, Jiahai
    Liu, Liyang
    Li, Xiaochuan
    Wu, Yaohong
    Wang, Deli
    Ruan, Dike
    EUROPEAN SPINE JOURNAL, 2017, 26 (03) : 606 - 618
  • [36] Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis
    Thomas Papathemelis
    S. Scharl
    K. Kronberger
    M. Gerken
    A. Scharl
    A. Pauer
    M. Klinkhammer-Schalke
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2555 - 2562
  • [37] Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis
    Papathemelis, Thomas
    Scharl, S.
    Kronberger, K.
    Gerken, M.
    Scharl, A.
    Pauer, A.
    Klinkhammer-Schalke, M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (12) : 2555 - 2562
  • [38] Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012
    Diaz-Aguilar, Daniel
    ReFaey, Karim
    Clifton, William
    Durcanova, Beata
    Chen, Selby G.
    Deen, H. Gordon
    Bydon, Mohamad
    Trifiletti, Daniel M.
    Pichelmann, Mark A.
    Quinones-Hinojosa, Alfredo
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 61 : 14 - 21
  • [39] Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhne-Alpes region
    Heudel, Pierre Etienne
    Cousin, Philippe
    Lurkin, Antoine
    Cropet, Claire
    Ducimetiere, Francoise
    Collard, Olivier
    De Laroche, Guy
    Biron, Pierre
    Meeus, Pierre
    Thiesse, Philippe
    Bergeron, Christophe
    Vaz, Gualter
    Mithieux, Francois
    Farsi, Fadila
    Fayet, Yohan
    Gilly, Francois-Noel
    Cellier, Dominic
    Blay, Jean-Yves
    Ray-Coquard, Isabelle
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 744 - 752
  • [40] A survival nomogram model constructed with common clinical characteristics to assist clinical decisions for diffuse low-grade gliomas: A population analysis based on SEER database
    Ao, Lei
    Shi, Dongjie
    Liu, Dan
    Yu, Hua
    Xu, Li
    Xia, Yongzhi
    Hao, Shilei
    Yang, Yaying
    Zhong, Wenjie
    Zhou, Junjie
    Xia, Haijian
    FRONTIERS IN ONCOLOGY, 2023, 13